カテゴリー： Market Monitor Global, 世界, 医療/バイオ

喉頭がん先進治療のグローバル市場展望 2023年-2029年：生物学的製剤、低分子治療

◆英語タイトル：Advanced Treatments for Laryngeal Cancer Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC12232）

◆商品コード：MMG23DC12232
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月（※2025年版があります。お問い合わせください。）
◆ページ数：69
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の喉頭がん先進治療市場規模と予測を収録しています。・世界の喉頭がん先進治療市場：売上、2018年-2023年、2024年-2029年
・世界の喉頭がん先進治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の喉頭がん先進治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「生物学的製剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

喉頭がん先進治療のグローバル主要企業は、Amgen Inc.、 AstraZeneca Plc、 Bayer AG、 Bristol Myers Squibb Co.、 Celldex Therapeutics Inc.、 Eli Lilly and Co.、 F. Hoffmann La Roche Ltd.、 Hangzhou Adlai Nortye Biopharma Co. Ltd.、 Hanmi Pharm Co. Ltd.、 Hikma Pharmaceuticals Plc、 Merck and Co. Inc.、 Pfizer Inc.、 Regeneron Pharmaceuticals Inc.、 Sanofiなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、喉頭がん先進治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の喉頭がん先進治療市場：タイプ別、2018年-2023年、2024年-2029年
世界の喉頭がん先進治療市場：タイプ別市場シェア、2022年
・生物学的製剤、低分子治療

世界の喉頭がん先進治療市場：用途別、2018年-2023年、2024年-2029年
世界の喉頭がん先進治療市場：用途別市場シェア、2022年
・病院、専門診療所、その他

世界の喉頭がん先進治療市場：地域・国別、2018年-2023年、2024年-2029年
世界の喉頭がん先進治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における喉頭がん先進治療のグローバル売上、2018年-2023年
・主要企業における喉頭がん先進治療のグローバル売上シェア、2022年
・主要企業における喉頭がん先進治療のグローバル販売量、2018年-2023年
・主要企業における喉頭がん先進治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Amgen Inc.、 AstraZeneca Plc、 Bayer AG、 Bristol Myers Squibb Co.、 Celldex Therapeutics Inc.、 Eli Lilly and Co.、 F. Hoffmann La Roche Ltd.、 Hangzhou Adlai Nortye Biopharma Co. Ltd.、 Hanmi Pharm Co. Ltd.、 Hikma Pharmaceuticals Plc、 Merck and Co. Inc.、 Pfizer Inc.、 Regeneron Pharmaceuticals Inc.、 Sanofi

*************************************************************

・調査・分析レポートの概要
喉頭がん先進治療市場の定義
市場セグメント
世界の喉頭がん先進治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の喉頭がん先進治療市場規模
世界の喉頭がん先進治療市場規模：2022年 VS 2029年
世界の喉頭がん先進治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの喉頭がん先進治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の喉頭がん先進治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：生物学的製剤、低分子治療
喉頭がん先進治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、専門診療所、その他
喉頭がん先進治療の用途別グローバル売上・予測

・地域別市場分析
地域別喉頭がん先進治療市場規模 2022年と2029年
地域別喉頭がん先進治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Amgen Inc.、 AstraZeneca Plc、 Bayer AG、 Bristol Myers Squibb Co.、 Celldex Therapeutics Inc.、 Eli Lilly and Co.、 F. Hoffmann La Roche Ltd.、 Hangzhou Adlai Nortye Biopharma Co. Ltd.、 Hanmi Pharm Co. Ltd.、 Hikma Pharmaceuticals Plc、 Merck and Co. Inc.、 Pfizer Inc.、 Regeneron Pharmaceuticals Inc.、 Sanofi
...

This research report provides a comprehensive analysis of the Advanced Treatments for Laryngeal Cancer market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Advanced Treatments for Laryngeal Cancer market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Advanced Treatments for Laryngeal Cancer, challenges faced by the industry, and potential opportunities for market players.
The global Advanced Treatments for Laryngeal Cancer market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Advanced Treatments for Laryngeal Cancer market presents opportunities for various stakeholders, including Hospital, Specialty Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Advanced Treatments for Laryngeal Cancer market. Additionally, the growing consumer demand present avenues for market expansion.
The global Advanced Treatments for Laryngeal Cancer market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Advanced Treatments for Laryngeal Cancer market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Advanced Treatments for Laryngeal Cancer market.
Market Overview: The report provides a comprehensive overview of the Advanced Treatments for Laryngeal Cancer market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Biologics, Small Molecule Therapy), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Advanced Treatments for Laryngeal Cancer market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Advanced Treatments for Laryngeal Cancer market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Advanced Treatments for Laryngeal Cancer market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Advanced Treatments for Laryngeal Cancer market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Advanced Treatments for Laryngeal Cancer market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Advanced Treatments for Laryngeal Cancer market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Advanced Treatments for Laryngeal Cancer, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Advanced Treatments for Laryngeal Cancer market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Advanced Treatments for Laryngeal Cancer market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Biologics
Small Molecule Therapy
Market segment by Application
Hospital
Specialty Clinic
Others
Global Advanced Treatments for Laryngeal Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Amgen Inc.
AstraZeneca Plc
Bayer AG
Bristol Myers Squibb Co.
Celldex Therapeutics Inc.
Eli Lilly and Co.
F. Hoffmann La Roche Ltd.
Hangzhou Adlai Nortye Biopharma Co. Ltd.
Hanmi Pharm Co. Ltd.
Hikma Pharmaceuticals Plc
Merck and Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Advanced Treatments for Laryngeal Cancer, market overview.
Chapter 2: Global Advanced Treatments for Laryngeal Cancer market size in revenue.
Chapter 3: Detailed analysis of Advanced Treatments for Laryngeal Cancer company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Advanced Treatments for Laryngeal Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Advanced Treatments for Laryngeal Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Advanced Treatments for Laryngeal Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Advanced Treatments for Laryngeal Cancer Overall Market Size
2.1 Global Advanced Treatments for Laryngeal Cancer Market Size: 2022 VS 2029
2.2 Global Advanced Treatments for Laryngeal Cancer Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Advanced Treatments for Laryngeal Cancer Players in Global Market
3.2 Top Global Advanced Treatments for Laryngeal Cancer Companies Ranked by Revenue
3.3 Global Advanced Treatments for Laryngeal Cancer Revenue by Companies
3.4 Top 3 and Top 5 Advanced Treatments for Laryngeal Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Advanced Treatments for Laryngeal Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Advanced Treatments for Laryngeal Cancer Players in Global Market
3.6.1 List of Global Tier 1 Advanced Treatments for Laryngeal Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Advanced Treatments for Laryngeal Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Advanced Treatments for Laryngeal Cancer Market Size Markets, 2022 & 2029
4.1.2 Biologics
4.1.3 Small Molecule Therapy
4.2 By Type – Global Advanced Treatments for Laryngeal Cancer Revenue & Forecasts
4.2.1 By Type – Global Advanced Treatments for Laryngeal Cancer Revenue, 2018-2023
4.2.2 By Type – Global Advanced Treatments for Laryngeal Cancer Revenue, 2024-2029
4.2.3 By Type – Global Advanced Treatments for Laryngeal Cancer Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Advanced Treatments for Laryngeal Cancer Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Specialty Clinic
5.1.4 Others
5.2 By Application – Global Advanced Treatments for Laryngeal Cancer Revenue & Forecasts
5.2.1 By Application – Global Advanced Treatments for Laryngeal Cancer Revenue, 2018-2023
5.2.2 By Application – Global Advanced Treatments for Laryngeal Cancer Revenue, 2024-2029
5.2.3 By Application – Global Advanced Treatments for Laryngeal Cancer Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Advanced Treatments for Laryngeal Cancer Market Size, 2022 & 2029
6.2 By Region – Global Advanced Treatments for Laryngeal Cancer Revenue & Forecasts
6.2.1 By Region – Global Advanced Treatments for Laryngeal Cancer Revenue, 2018-2023
6.2.2 By Region – Global Advanced Treatments for Laryngeal Cancer Revenue, 2024-2029
6.2.3 By Region – Global Advanced Treatments for Laryngeal Cancer Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Advanced Treatments for Laryngeal Cancer Revenue, 2018-2029
6.3.2 US Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
6.3.3 Canada Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
6.3.4 Mexico Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Advanced Treatments for Laryngeal Cancer Revenue, 2018-2029
6.4.2 Germany Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
6.4.3 France Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
6.4.4 U.K. Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
6.4.5 Italy Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
6.4.6 Russia Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
6.4.7 Nordic Countries Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
6.4.8 Benelux Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Advanced Treatments for Laryngeal Cancer Revenue, 2018-2029
6.5.2 China Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
6.5.3 Japan Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
6.5.4 South Korea Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
6.5.5 Southeast Asia Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
6.5.6 India Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Advanced Treatments for Laryngeal Cancer Revenue, 2018-2029
6.6.2 Brazil Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
6.6.3 Argentina Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Advanced Treatments for Laryngeal Cancer Revenue, 2018-2029
6.7.2 Turkey Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
6.7.3 Israel Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
6.7.4 Saudi Arabia Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
6.7.5 UAE Advanced Treatments for Laryngeal Cancer Market Size, 2018-2029
7 Advanced Treatments for Laryngeal Cancer Companies Profiles
7.1 Amgen Inc.
7.1.1 Amgen Inc. Company Summary
7.1.2 Amgen Inc. Business Overview
7.1.3 Amgen Inc. Advanced Treatments for Laryngeal Cancer Major Product Offerings
7.1.4 Amgen Inc. Advanced Treatments for Laryngeal Cancer Revenue in Global Market (2018-2023)
7.1.5 Amgen Inc. Key News & Latest Developments
7.2 AstraZeneca Plc
7.2.1 AstraZeneca Plc Company Summary
7.2.2 AstraZeneca Plc Business Overview
7.2.3 AstraZeneca Plc Advanced Treatments for Laryngeal Cancer Major Product Offerings
7.2.4 AstraZeneca Plc Advanced Treatments for Laryngeal Cancer Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca Plc Key News & Latest Developments
7.3 Bayer AG
7.3.1 Bayer AG Company Summary
7.3.2 Bayer AG Business Overview
7.3.3 Bayer AG Advanced Treatments for Laryngeal Cancer Major Product Offerings
7.3.4 Bayer AG Advanced Treatments for Laryngeal Cancer Revenue in Global Market (2018-2023)
7.3.5 Bayer AG Key News & Latest Developments
7.4 Bristol Myers Squibb Co.
7.4.1 Bristol Myers Squibb Co. Company Summary
7.4.2 Bristol Myers Squibb Co. Business Overview
7.4.3 Bristol Myers Squibb Co. Advanced Treatments for Laryngeal Cancer Major Product Offerings
7.4.4 Bristol Myers Squibb Co. Advanced Treatments for Laryngeal Cancer Revenue in Global Market (2018-2023)
7.4.5 Bristol Myers Squibb Co. Key News & Latest Developments
7.5 Celldex Therapeutics Inc.
7.5.1 Celldex Therapeutics Inc. Company Summary
7.5.2 Celldex Therapeutics Inc. Business Overview
7.5.3 Celldex Therapeutics Inc. Advanced Treatments for Laryngeal Cancer Major Product Offerings
7.5.4 Celldex Therapeutics Inc. Advanced Treatments for Laryngeal Cancer Revenue in Global Market (2018-2023)
7.5.5 Celldex Therapeutics Inc. Key News & Latest Developments
7.6 Eli Lilly and Co.
7.6.1 Eli Lilly and Co. Company Summary
7.6.2 Eli Lilly and Co. Business Overview
7.6.3 Eli Lilly and Co. Advanced Treatments for Laryngeal Cancer Major Product Offerings
7.6.4 Eli Lilly and Co. Advanced Treatments for Laryngeal Cancer Revenue in Global Market (2018-2023)
7.6.5 Eli Lilly and Co. Key News & Latest Developments
7.7 F. Hoffmann La Roche Ltd.
7.7.1 F. Hoffmann La Roche Ltd. Company Summary
7.7.2 F. Hoffmann La Roche Ltd. Business Overview
7.7.3 F. Hoffmann La Roche Ltd. Advanced Treatments for Laryngeal Cancer Major Product Offerings
7.7.4 F. Hoffmann La Roche Ltd. Advanced Treatments for Laryngeal Cancer Revenue in Global Market (2018-2023)
7.7.5 F. Hoffmann La Roche Ltd. Key News & Latest Developments
7.8 Hangzhou Adlai Nortye Biopharma Co. Ltd.
7.8.1 Hangzhou Adlai Nortye Biopharma Co. Ltd. Company Summary
7.8.2 Hangzhou Adlai Nortye Biopharma Co. Ltd. Business Overview
7.8.3 Hangzhou Adlai Nortye Biopharma Co. Ltd. Advanced Treatments for Laryngeal Cancer Major Product Offerings
7.8.4 Hangzhou Adlai Nortye Biopharma Co. Ltd. Advanced Treatments for Laryngeal Cancer Revenue in Global Market (2018-2023)
7.8.5 Hangzhou Adlai Nortye Biopharma Co. Ltd. Key News & Latest Developments
7.9 Hanmi Pharm Co. Ltd.
7.9.1 Hanmi Pharm Co. Ltd. Company Summary
7.9.2 Hanmi Pharm Co. Ltd. Business Overview
7.9.3 Hanmi Pharm Co. Ltd. Advanced Treatments for Laryngeal Cancer Major Product Offerings
7.9.4 Hanmi Pharm Co. Ltd. Advanced Treatments for Laryngeal Cancer Revenue in Global Market (2018-2023)
7.9.5 Hanmi Pharm Co. Ltd. Key News & Latest Developments
7.10 Hikma Pharmaceuticals Plc
7.10.1 Hikma Pharmaceuticals Plc Company Summary
7.10.2 Hikma Pharmaceuticals Plc Business Overview
7.10.3 Hikma Pharmaceuticals Plc Advanced Treatments for Laryngeal Cancer Major Product Offerings
7.10.4 Hikma Pharmaceuticals Plc Advanced Treatments for Laryngeal Cancer Revenue in Global Market (2018-2023)
7.10.5 Hikma Pharmaceuticals Plc Key News & Latest Developments
7.11 Merck and Co. Inc.
7.11.1 Merck and Co. Inc. Company Summary
7.11.2 Merck and Co. Inc. Business Overview
7.11.3 Merck and Co. Inc. Advanced Treatments for Laryngeal Cancer Major Product Offerings
7.11.4 Merck and Co. Inc. Advanced Treatments for Laryngeal Cancer Revenue in Global Market (2018-2023)
7.11.5 Merck and Co. Inc. Key News & Latest Developments
7.12 Pfizer Inc.
7.12.1 Pfizer Inc. Company Summary
7.12.2 Pfizer Inc. Business Overview
7.12.3 Pfizer Inc. Advanced Treatments for Laryngeal Cancer Major Product Offerings
7.12.4 Pfizer Inc. Advanced Treatments for Laryngeal Cancer Revenue in Global Market (2018-2023)
7.12.5 Pfizer Inc. Key News & Latest Developments
7.13 Regeneron Pharmaceuticals Inc.
7.13.1 Regeneron Pharmaceuticals Inc. Company Summary
7.13.2 Regeneron Pharmaceuticals Inc. Business Overview
7.13.3 Regeneron Pharmaceuticals Inc. Advanced Treatments for Laryngeal Cancer Major Product Offerings
7.13.4 Regeneron Pharmaceuticals Inc. Advanced Treatments for Laryngeal Cancer Revenue in Global Market (2018-2023)
7.13.5 Regeneron Pharmaceuticals Inc. Key News & Latest Developments
7.14 Sanofi
7.14.1 Sanofi Company Summary
7.14.2 Sanofi Business Overview
7.14.3 Sanofi Advanced Treatments for Laryngeal Cancer Major Product Offerings
7.14.4 Sanofi Advanced Treatments for Laryngeal Cancer Revenue in Global Market (2018-2023)
7.14.5 Sanofi Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Advanced Treatments for Laryngeal Cancer Market Opportunities & Trends in Global Market
Table 2. Advanced Treatments for Laryngeal Cancer Market Drivers in Global Market
Table 3. Advanced Treatments for Laryngeal Cancer Market Restraints in Global Market
Table 4. Key Players of Advanced Treatments for Laryngeal Cancer in Global Market
Table 5. Top Advanced Treatments for Laryngeal Cancer Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Advanced Treatments for Laryngeal Cancer Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Advanced Treatments for Laryngeal Cancer Revenue Share by Companies, 2018-2023
Table 8. Global Companies Advanced Treatments for Laryngeal Cancer Product Type
Table 9. List of Global Tier 1 Advanced Treatments for Laryngeal Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Advanced Treatments for Laryngeal Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Advanced Treatments for Laryngeal Cancer Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Advanced Treatments for Laryngeal Cancer Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Advanced Treatments for Laryngeal Cancer Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Advanced Treatments for Laryngeal Cancer Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Advanced Treatments for Laryngeal Cancer Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Advanced Treatments for Laryngeal Cancer Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2024-2029
Table 30. Amgen Inc. Company Summary
Table 31. Amgen Inc. Advanced Treatments for Laryngeal Cancer Product Offerings
Table 32. Amgen Inc. Advanced Treatments for Laryngeal Cancer Revenue (US$, Mn) & (2018-2023)
Table 33. Amgen Inc. Key News & Latest Developments
Table 34. AstraZeneca Plc Company Summary
Table 35. AstraZeneca Plc Advanced Treatments for Laryngeal Cancer Product Offerings
Table 36. AstraZeneca Plc Advanced Treatments for Laryngeal Cancer Revenue (US$, Mn) & (2018-2023)
Table 37. AstraZeneca Plc Key News & Latest Developments
Table 38. Bayer AG Company Summary
Table 39. Bayer AG Advanced Treatments for Laryngeal Cancer Product Offerings
Table 40. Bayer AG Advanced Treatments for Laryngeal Cancer Revenue (US$, Mn) & (2018-2023)
Table 41. Bayer AG Key News & Latest Developments
Table 42. Bristol Myers Squibb Co. Company Summary
Table 43. Bristol Myers Squibb Co. Advanced Treatments for Laryngeal Cancer Product Offerings
Table 44. Bristol Myers Squibb Co. Advanced Treatments for Laryngeal Cancer Revenue (US$, Mn) & (2018-2023)
Table 45. Bristol Myers Squibb Co. Key News & Latest Developments
Table 46. Celldex Therapeutics Inc. Company Summary
Table 47. Celldex Therapeutics Inc. Advanced Treatments for Laryngeal Cancer Product Offerings
Table 48. Celldex Therapeutics Inc. Advanced Treatments for Laryngeal Cancer Revenue (US$, Mn) & (2018-2023)
Table 49. Celldex Therapeutics Inc. Key News & Latest Developments
Table 50. Eli Lilly and Co. Company Summary
Table 51. Eli Lilly and Co. Advanced Treatments for Laryngeal Cancer Product Offerings
Table 52. Eli Lilly and Co. Advanced Treatments for Laryngeal Cancer Revenue (US$, Mn) & (2018-2023)
Table 53. Eli Lilly and Co. Key News & Latest Developments
Table 54. F. Hoffmann La Roche Ltd. Company Summary
Table 55. F. Hoffmann La Roche Ltd. Advanced Treatments for Laryngeal Cancer Product Offerings
Table 56. F. Hoffmann La Roche Ltd. Advanced Treatments for Laryngeal Cancer Revenue (US$, Mn) & (2018-2023)
Table 57. F. Hoffmann La Roche Ltd. Key News & Latest Developments
Table 58. Hangzhou Adlai Nortye Biopharma Co. Ltd. Company Summary
Table 59. Hangzhou Adlai Nortye Biopharma Co. Ltd. Advanced Treatments for Laryngeal Cancer Product Offerings
Table 60. Hangzhou Adlai Nortye Biopharma Co. Ltd. Advanced Treatments for Laryngeal Cancer Revenue (US$, Mn) & (2018-2023)
Table 61. Hangzhou Adlai Nortye Biopharma Co. Ltd. Key News & Latest Developments
Table 62. Hanmi Pharm Co. Ltd. Company Summary
Table 63. Hanmi Pharm Co. Ltd. Advanced Treatments for Laryngeal Cancer Product Offerings
Table 64. Hanmi Pharm Co. Ltd. Advanced Treatments for Laryngeal Cancer Revenue (US$, Mn) & (2018-2023)
Table 65. Hanmi Pharm Co. Ltd. Key News & Latest Developments
Table 66. Hikma Pharmaceuticals Plc Company Summary
Table 67. Hikma Pharmaceuticals Plc Advanced Treatments for Laryngeal Cancer Product Offerings
Table 68. Hikma Pharmaceuticals Plc Advanced Treatments for Laryngeal Cancer Revenue (US$, Mn) & (2018-2023)
Table 69. Hikma Pharmaceuticals Plc Key News & Latest Developments
Table 70. Merck and Co. Inc. Company Summary
Table 71. Merck and Co. Inc. Advanced Treatments for Laryngeal Cancer Product Offerings
Table 72. Merck and Co. Inc. Advanced Treatments for Laryngeal Cancer Revenue (US$, Mn) & (2018-2023)
Table 73. Merck and Co. Inc. Key News & Latest Developments
Table 74. Pfizer Inc. Company Summary
Table 75. Pfizer Inc. Advanced Treatments for Laryngeal Cancer Product Offerings
Table 76. Pfizer Inc. Advanced Treatments for Laryngeal Cancer Revenue (US$, Mn) & (2018-2023)
Table 77. Pfizer Inc. Key News & Latest Developments
Table 78. Regeneron Pharmaceuticals Inc. Company Summary
Table 79. Regeneron Pharmaceuticals Inc. Advanced Treatments for Laryngeal Cancer Product Offerings
Table 80. Regeneron Pharmaceuticals Inc. Advanced Treatments for Laryngeal Cancer Revenue (US$, Mn) & (2018-2023)
Table 81. Regeneron Pharmaceuticals Inc. Key News & Latest Developments
Table 82. Sanofi Company Summary
Table 83. Sanofi Advanced Treatments for Laryngeal Cancer Product Offerings
Table 84. Sanofi Advanced Treatments for Laryngeal Cancer Revenue (US$, Mn) & (2018-2023)
Table 85. Sanofi Key News & Latest Developments
List of Figures
Figure 1. Advanced Treatments for Laryngeal Cancer Segment by Type in 2022
Figure 2. Advanced Treatments for Laryngeal Cancer Segment by Application in 2022
Figure 3. Global Advanced Treatments for Laryngeal Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Advanced Treatments for Laryngeal Cancer Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Advanced Treatments for Laryngeal Cancer Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Advanced Treatments for Laryngeal Cancer Revenue in 2022
Figure 8. By Type - Global Advanced Treatments for Laryngeal Cancer Revenue Market Share, 2018-2029
Figure 9. By Application - Global Advanced Treatments for Laryngeal Cancer Revenue Market Share, 2018-2029
Figure 10. By Type - Global Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Advanced Treatments for Laryngeal Cancer Revenue Market Share, 2018-2029
Figure 12. By Application - Global Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Advanced Treatments for Laryngeal Cancer Revenue Market Share, 2018-2029
Figure 14. By Region - Global Advanced Treatments for Laryngeal Cancer Revenue Market Share, 2018-2029
Figure 15. By Country - North America Advanced Treatments for Laryngeal Cancer Revenue Market Share, 2018-2029
Figure 16. US Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Advanced Treatments for Laryngeal Cancer Revenue Market Share, 2018-2029
Figure 20. Germany Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 21. France Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Advanced Treatments for Laryngeal Cancer Revenue Market Share, 2018-2029
Figure 28. China Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 32. India Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Advanced Treatments for Laryngeal Cancer Revenue Market Share, 2018-2029
Figure 34. Brazil Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Advanced Treatments for Laryngeal Cancer Revenue Market Share, 2018-2029
Figure 37. Turkey Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Advanced Treatments for Laryngeal Cancer Revenue, (US$, Mn), 2018-2029
Figure 41. Amgen Inc. Advanced Treatments for Laryngeal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca Plc Advanced Treatments for Laryngeal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bayer AG Advanced Treatments for Laryngeal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bristol Myers Squibb Co. Advanced Treatments for Laryngeal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Celldex Therapeutics Inc. Advanced Treatments for Laryngeal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Eli Lilly and Co. Advanced Treatments for Laryngeal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. F. Hoffmann La Roche Ltd. Advanced Treatments for Laryngeal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Hangzhou Adlai Nortye Biopharma Co. Ltd. Advanced Treatments for Laryngeal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Hanmi Pharm Co. Ltd. Advanced Treatments for Laryngeal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Hikma Pharmaceuticals Plc Advanced Treatments for Laryngeal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Merck and Co. Inc. Advanced Treatments for Laryngeal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Pfizer Inc. Advanced Treatments for Laryngeal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Regeneron Pharmaceuticals Inc. Advanced Treatments for Laryngeal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Sanofi Advanced Treatments for Laryngeal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

※参考情報

喉頭がんは、喉頭（のどの一部である声帯を含む）に発生する悪性腫瘍であり、その治療にはさまざまなアプローチがあります。近年、医療技術の進歩により、喉頭がんの治療においても先進的なアプローチが取られるようになりました。先進治療とは、最新の研究成果や技術を用いて、より効果的かつ患者に優しい治療法を提供することを指します。本稿では、喉頭がんの先進治療の概念について、定義、特徴、種類、用途、関連技術などを詳しく述べます。

まず、喉頭がんの定義について説明します。喉頭がんは、ほとんどが扁平上皮癌で構成され、喉頭の組織で発生する癌です。喉頭は音声生成に関与し、呼吸道の一部でもあるため、この部位に癌が発生すると、音声や呼吸に影響を及ぼす可能性があります。また、喉頭がんのリスクファクターには、喫煙やアルコール摂取、ウイルス感染（特にヒトパピローマウイルス）が含まれます。

喉頭がんの先進治療は、従来の外科手術、放射線療法、化学療法に加えて、新たなアプローチを含んでいます。これには、標的療法や免疫療法、放射線療法の強化版などが含まれます。これらの治療法は、より精密に癌細胞を攻撃し、周囲の正常な組織への影響を最小限に抑えることを目的としています。

特徴として、喉頭がんの先進治療は、個々の患者に合わせたオーダーメイド治療の傾向があります。従来の方法では一律の治療計画が立てられることが一般的でしたが、現在では遺伝子検査やバイオマーカーを用いて、患者一人ひとりの腫瘍特性を把握し、それに基づいた治療が行われるようになっています。これにより、より高い治療効果を期待できるとともに、副作用の軽減も図られています。

喉頭がんの先進治療には、いくつかの種類があります。まず、標的療法についてです。これは、癌細胞の特定の分子を標的とする治療法で、例えばHER2陽性の腫瘍に対してはその分子を狙った薬剤が使用されます。これにより、正常な細胞に対する影響を極力抑えつつ、癌細胞を効果的に攻撃することが可能です。

次に、免疫療法があります。この治療法は、患者自身の免疫系を活性化させ、癌細胞を排除することを目的としています。PD-1阻害剤やCTLA-4阻害剤など、新たに開発された薬剤が用いられ、多くの場合、腫瘍の縮小や進行の抑制が見込まれています。最近の研究では、これらの免疫療法が喉頭がんに対しても有効であることが示されています。

さらに、放射線療法の技術も進化しています。従来の放射線療法は、広範囲に放射線を照射するものでしたが、現在では、強度変調放射線治療（IMRT）や画像誘導放射線治療（IGRT）など、より精度の高い技術が導入されています。これにより、治療時の正常組織への影響を最小限に抑えつつ、癌細胞に対しては高い効果をもたらします。

こうした先進治療の用途についても触れておきます。喉頭がんの治療においては、初期段階から進行がんまで、さまざまなステージに適応されることが多いです。特に、手術に伴うリスクが高い患者や、再発のリスクが高い患者に対しては、これらの先進的な治療法が有効であると考えられています。

関連技術としては、遺伝子解析やバイオマーカーの検出技術が挙げられます。これらの技術により、腫瘍の特性を診断し、患者ごとの最適な治療法を導き出すことが優先されています。また、新たな治療法としての臨床試験も進行しており、新しい治療薬やアプローチが常に模索されています。

以上のように、喉頭がんに対する先進治療は、医療技術の進歩に伴い変化し続けています。患者一人ひとりの病状に適した治療法を選択することで、より高い治療効果が期待でき、副作用の軽減にも寄与しています。今後もこの分野の進展が待たれます。治療法の進化がもたらす新たな可能性に注目し、患者がより良い選択をできるような環境が提供されることが重要です。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 喉頭がん先進治療のグローバル市場展望 2023年-2029年：生物学的製剤、低分子治療(Advanced Treatments for Laryngeal Cancer Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

喉頭がん先進治療のグローバル市場展望 2023年-2029年：生物学的製剤、低分子治療

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp